ProPhase Labs, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Amount
ProPhase Labs, Inc. (PRPH) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Amount of $1.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2017-02-24.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseCharitableContributions · last filed 2017-02-24
- ProPhase Labs, Inc. effective income tax rate reconciliation, nondeductible expense, charitable contributions, amount for fiscal 2014 was $1.00K, a 0.00% change from fiscal 2013.
- ProPhase Labs, Inc. effective income tax rate reconciliation, nondeductible expense, charitable contributions, amount for fiscal 2013 was $1.00K, a 75.00% decline from fiscal 2012.
- ProPhase Labs, Inc. effective income tax rate reconciliation, nondeductible expense, charitable contributions, amount for fiscal 2012 was $4.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Charitable Contributions, Amount 12 month |
|---|---|
| 2014-12-31 | $1.00K 10-K · filed 2017-02-24 |
| 2013-12-31 | $1.00K 10-K · filed 2016-03-29 |
| 2012-12-31 | $4.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |